Библиографическая ссылка:
Brian G.Н., Bonanno P.V., Bucsics A.Н., Oortwijn W.Н., Rothe C.C., Ferrario A.Н., Bosselli S.Н., Hill A.Н., Martin A.P., Simoens S.Н., Kurdi A., Gad M., Gulbinovic J., Timoney A., Bochenek T., Salem A., Hoxha I., Sauermann R., Massele A., Guerra Jr. A. A., Petrova G., Mitkova Z., Achniotou G., Laius O., Sermet C., Selke G., Kourafalos V., Yfantopoulos J., Magnusson E., Joppi R., Oluka M., Hye-Young Kwon -., Jakupi A., Kalemeera F., Fadare J. O., Melien O., Pomorski M., Wladysiuk M., Markovic´ -Pekovic V., Mardare I., Novakovic T., Furst J., Tomek D., Zara C., Diogene E., Meyer J.C., Malmstrom R.E., Wettermark B., Matsebula Z., Campbell S., Haycox A., Мешков Д.О. Barriers for Access to New Medicines: Searching for the balance between rising costs and limited budgets // Frontiers in Public Health. 2018. December 2018, Volume 6. С. Article 328.